The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Neurotoxic microglial activation via IFNγ-Induced Nrf2 reduction exacerbating alzheimer's disease
Abstract
Microglial neuroinflammation appears to be neuroprotective in the early pathological stage, yet neurotoxic, which often precedes neurodegeneration in Alzheimer's disease (AD). However, it remains unclear how the microglial activities transit to the neurotoxic state during AD progression, due to complex neuron‐glia interactions. Here, the mechanism of detrimental microgliosis in AD by employing 3D human AD mini‐brains, brain tissues of AD patients, and 5XFAD mice is explored. In the human and animal AD models, amyloid‐beta (Aβ)‐overexpressing neurons and reactive astrocytes produce interferon‐gamma (IFNγ) and excessive oxidative stress. IFNγ results in the downregulation of mitogen‐activated protein kinase (MAPK) and the upregulation of Kelch‐like ECH‐associated Protein 1 (Keap1) in microglia, which inactivate nuclear factor erythroid‐2‐related factor 2 (Nrf2) and sensitize microglia to the oxidative stress and induces a proinflammatory microglia via nuclear factor kappa B (NFκB)‐axis. The proinflammatory microglia in turn produce neurotoxic nitric oxide and proinflammatory mediators exacerbating synaptic impairment, phosphorylated‐tau accumulation, and discernable neuronal loss. Interestingly, recovering Nrf2 in the microglia prevents the activation of proinflammatory microglia and significantly blocks the tauopathy in AD minibrains. Taken together, it is envisioned that IFNγ‐driven Nrf2 downregulation in microglia as a key target to ameliorate AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic neuroinflammation is implicated in disease pathogenesis, as demonstrated in vivo”
From Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters (2025) · cites this paper as Kang et al., 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070
Microglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999
Microglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935
Roles of IFN-γ in tumor progression and regression: A review
Jorgovanovic, D., Song, M., Wang, L., & Zhang, Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00228-x · Cited by 1,234
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154
Self-citation
Research works printed but not linked: 45
- 10.1002/alz.12278 · doi:10.1002/alz.12278
- 10.3389/fnagi.2018.00359 · DOI
- González‐Reyes R. E., 2017, Frontiers, 10, 427
- 10.1038/s41593-020-00735-y · DOI · Paper page
- 10.3233/JAD-161118 · DOI · Paper page
- 10.1523/JNEUROSCI.22-02-00486.2002 · DOI · Paper page
- 10.1016/S0197-4580(00)00124-X · DOI · Paper page
- 10.1016/j.trci.2018.06.014 · DOI · Paper page
- 10.1046/j.1471-4159.1998.70020699.x · DOI · Paper page
- 10.1016/S0306-4522(98)00219-X · DOI · Paper page
- 10.1016/S0165-0173(00)00030-8 · DOI · Paper page
- 10.1016/j.cell.2017.05.018 · DOI · Paper page
- 10.51335/organoid.2021.1.e5 · DOI
- 10.1038/s41551-020-00643-3 · DOI
- 10.1038/srep01823 · DOI
- 10.1073/pnas.222681699 · DOI · Paper page
- 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
- 10.1016/j.ceb.2015.02.004 · DOI · Paper page
- 10.3389/fnana.2017.00077 · DOI · Paper page
- 10.1177/1744806918781733 · DOI
- 10.1111/cns.13061 · DOI · Paper page
- 10.1016/j.bbadis.2018.11.007 · DOI · Paper page
- 10.1523/JNEUROSCI.18-24-10445.1998 · DOI · Paper page
- 10.1016/0891-0618(96)00148-2 · DOI · Paper page
- 10.1038/s41598-020-58422-8 · DOI · Paper page
- 10.1155/2015/352723 · DOI · Paper page
- 10.1002/glia.22762 · DOI
- 10.1089/ars.2017.7342 · DOI · Paper page
- 10.1073/pnas.1819541116 · DOI · Paper page
- Baird L., 2020, Mol. Cell. Biol., 40
- 10.1093/toxsci/kfg083 · DOI · Paper page
- 10.3390/antiox11122377 · DOI · Paper page
- 10.1016/j.molmed.2023.07.008 · DOI
- 10.1038/s41573-018-0008-x · DOI · Paper page
- 10.1126/sciadv.abc1428 · DOI
- 10.1126/sciadv.abo0789 · DOI
- 10.1021/acsami.9b23004 · DOI
- 10.4110/in.2018.18.e33 · DOI · Paper page
- 10.18632/oncotarget.16990 · DOI
- 10.3389/fimmu.2015.00539 · DOI
- 10.1371/journal.pone.0162497 · DOI
- 10.1046/j.1365-2567.1996.456544.x · DOI
- 10.1073/pnas.052159099 · DOI
- 10.1016/S0140-6736(16)31679-8 · DOI · Paper page
- 10.1111/acel.13153 · DOI
Cited by
Laloli, K. J., Rentsch, P., Stayte, S., & Vissel, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1682979 · Cited by 3
Metadata
- Authors
- Kang, Y. J., Hyeon, S. J., McQuade, A., Lim, J., Baek, S. H., Diep, Y. N., Do, K. V., Jeon, Y., Jo, D., Lee, C. J., Blurton‐Jones, M., Ryu, H., & Cho, H.
- Affiliations
- Institute of Quantum Biophysics Sungkyunkwan University Suwon Gyeonggi 16419 Republic of Korea
- Center for Brain Disorders Brain Science Institute Korea Institute of Science and Technology Seoul 02792 Republic of Korea
- Institute for Neurodegenerative Diseases University of California San Francisco CA 94158 USA
- IBS School University of Science and Technology (UST) Daejeon 34114 Republic of Korea
- School of Pharmacy Sungkyunkwan University Suwon Gyeonggi 16419 Republic of Korea
- Center for Cognition and Sociality Institute for Basic Science (IBS) Daejeon 34126 Republic of Korea
- Department of Neurobiology & Behavior University of California Irvine Irvine CA 92697 USA
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2024-03-14
- Volume
- 11
- Issue
- 20
- ISSN
- 2198-3844
- Cited by
- 27
- References
- 26
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- Korea Health Industry Development Institute
- Korea Dementia Research Center
- National Research Foundation of Korea (NRF‐2020R1A2C2010285, NRF‐I21SS7606036, NRF‐2022R1I1A1A01063094, NRF‐2022R1I1A1A01072791, NRF‐2021R1C1C2095827, NRF‐2020M3E5D9079742, NRF‐2022R1A2C3013138)
- Cure Alzheimer's Fund
- Ministry of Science and ICT, South Korea (HU22C0115, HU23C0217)
- Korea National Institute of Health (NIH‐AG059236‐01A1, NIH‐AG056303, NIH‐AG055524, NIH‐AG06970101, NIH‐DA048813)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.